PHK
NBIX icon

Point72 Hong Kong’s Neurocrine Biosciences NBIX Stock Holding History

Point72 Hong Kong’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$283K Buy
+2,019
New +$274K 0.01% 294
2022
Q2 		– Sell
-6,951
Closed -$652K – 2251
2022
Q1 		$652K Buy
6,951
+4,331
+165% +$367K 0.02% 637
2021
Q4 		$223K Buy
+2,620
New +$241K 0.01% 990
2021
Q3 		– Sell
-17,877
Closed -$1.74M – 2293
2021
Q2 		$1.74M Buy
+17,877
New +$1.71M 0.06% 484
2021
Q1 		– Sell
-8,107
Closed -$777K – 2077
2020
Q4 		$777K Sell
8,107
-6,281
-44% -$607K 0.04% 573
2020
Q3 		$1.38M Buy
+14,388
New +$1.66M 0.15% 161
2020
Q2 		– Sell
-446
Closed -$39K – 1330
2020
Q1 		$39K Sell
446
-2,056
-82% -$201K 0.02% 404
2019
Q4 		$269K Buy
2,502
+546
+28% +$57.2K 0.06% 263
2019
Q3 		$176K Buy
+1,956
New +$183K 0.05% 329
2019
Q2 		– Sell
-1,434
Closed -$126K – 1302
2019
Q1 		$126K Buy
+1,434
New +$120K 0.05% 300
2018
Q4 		– Sell
-492
Closed -$60K – 1097
2018
Q3 		$60K Buy
+492
New +$55.8K 0.02% 431
2018
Q2 		– Sell
-233
Closed -$19K – 1097
2018
Q1 		$19K Buy
+233
New +$19.7K 0.01% 625
2017
Q1 		– Sell
-7,267
Closed -$281K – 886
2016
Q4 		$281K Buy
7,267
+6,267
+627% +$284K 0.28% 101
2016
Q3 		$51K Buy
+1,000
New +$49.8K 0.03% 467

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's NBIX Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Neurocrine Biosciences (NBIX) in Q3 2025: 2,019 shares worth $283K. The stake represents 0.01% of the portfolio and ranks #294 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in NBIX as recently as Q1 2022.

Point72 Hong Kong first reported a position in NBIX in Q3 2016 and has held it in 14 quarters since. The position peaked at $1.74M in Q2 2021. 650 funds tracked by Wall St. Rank hold NBIX as of Q3 2025.

  • Point72 Hong Kong held 2,019 shares of Neurocrine Biosciences worth $283K as of Q3 2025.
  • Neurocrine Biosciences was a new Point72 Hong Kong position in Q3 2025.
  • Neurocrine Biosciences made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #294 holding.
  • Point72 Hong Kong first reported a position in Neurocrine Biosciences in Q3 2016 and has held it in 14 quarters since.
  • Point72 Hong Kong's Neurocrine Biosciences position peaked at $1.74M in Q2 2021.
  • 650 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.